RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19493232http://www.w3.org/2000/01/rdf-schema#comment"We have analysed the frequency of killer immunoglobulin-like receptors (KIR) in cohorts of patients from Turkey with acute lymphocyte leukaemia (n = 52), acute myeloid leukaemia (n = 54) and chronic myeloid leukaemia (CML) (n = 52) and compared the results with 154 controls. We also examined the frequencies of human leucocyte antigen (HLA)-C groups, -Bw4, -Bw6 and where appropriate the combination of the KIR gene and its ligand. We found several statistically significant results between the patients and the controls. We proposed a model in CML of protection via KIR2DL2 and/or KIR2DS2 with the presence of the ligand HLA-C1 group and susceptibility via HLA-Bw4 homozygosity (i.e. absence of HLA-Bw6)."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.org/dc/terms/identifier"doi:10.1111/j.1399-0039.2009.01235.x"xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/author"Middleton D."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/author"Diler A.S."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/author"Meenagh A."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/author"Sleator C."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/author"Gourraud P.A."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/name"Tissue Antigens"xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/pages"553-560"xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/title"Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia."xsd:string
http://purl.uniprot.org/citations/19493232http://purl.uniprot.org/core/volume"73"xsd:string
http://purl.uniprot.org/citations/19493232http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19493232
http://purl.uniprot.org/citations/19493232http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19493232
http://purl.uniprot.org/uniprot/#_A0A0A7C548-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0A7C549-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0A7C551-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0A7C552-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0A7C553-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0E3DC98-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0E3DCA0-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0E3DCA1-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0G2R0N3-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232
http://purl.uniprot.org/uniprot/#_A0A0G2R0N4-mappedCitation-19493232http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19493232